Recombinant
vaccines are produced by using recombinant DNA technology or genetic
engineering for the prevention of lethal diseases in human beings and
animals. Recombinant vaccine is a biological preparation that
provides active acquired immunity against a certain disease. Whereas
individual being vaccinated produces antibodies against the protein
antigen that protect a person from contracting the disease upon
attack from the pathogenic microorganism. These vaccines functions on
the immune response for diseases and to have preventive measures
against diseases caused by various bacteria, and virus. These
vaccines are much more advanced and effective as compare to
conventional vaccines in the prevention of diseases such as malaria,
typhoid, and human papillomavirus (HPV). Furthermore, Europe
dominates the animal recombinant vaccines market as compared to other
regions due to highly organized livestock and major demand for
livestock products in Europe.
Get
Free Exclusive PDF Sample Copy of This Report @
https://www.coherentmarketinsights.com/insight/request-pdf/455
Market
Dynamics:
The
recent past has witnessed a steady rise in incidence of zoonotic and
infectious diseases in humans and animals as well, which lead to the
increased research & developments for the innovation of new and
effective recombinant vaccines for the prevention of diseases.
Government has also taken an initiative to increase awareness
regarding vaccination to prevent diseases in community. Manufacturing
companies have also started some beneficial programs to provide
vaccination free of cost to poor people, which creates a highly
conducive environment for growth of the recombinant vaccines market
in near future. National Immunization Program by Queensland
Government in Australia and Indradhanush vaccination program in India
works to provide vaccination among children throughout the nation.
Various organizations such as World Health Organization, World Bank,
and United Nations Children’s Funds has also taken and initiative
to increase vaccination.
The
global recombinant vaccine market was valued at US$ 830.2 million in
2016 and is expected to witness a robust CAGR of 6.0% during the
forecast period (2017 – 2025).
Increase
in the incidence of zoonotic diseases and emerging technologies
expected to support the growth of recombinant vaccines market
There
is a constant increase in diseases caused by bacteria or virus such
as swine flu, malaria, HPV and other diseases, which has raised the
demand of vaccination and lead to the eradication of diseases such as
polio, and tetanus in few countries. Whit the development in
technology there is development in vaccines, which are more effective
than conventional vaccines and does not lead to any side effect.
These vaccines are easy to administer in the body orally,
intramuscular or intradermal. In the U.S. there were around 212
million malaria cases and 429,000 deaths from malaria is reported in
2015. According to Centers for Disease Control and Prevention report
2017, in the U.S. there were around 49.9% of the children between the
ages of 6 months to 17 years received an influenza vaccine.
Top
Key Players:
Some
major key players in the recombinant vaccines market include Merck &
Co. Inc., Novartis AG, Protein Science Corporation, GlaxoSmithKline
Plc., Green Cross Corporation, Bayer AG, Sanofi S A, Pfizer Inc., and
Bharat Biotech.
Detailed
Segmentation:
Global
Recombinant Vaccines Market, By Product Type -
-
Subunit Recombinant Vaccines
-
Attenuated Recombinant Vaccines
-
Vector Recombinant Vaccines
Global
Recombinant Vaccines Market, By Disease Type -
-
Infectious Disease
-
Cancer
-
Allergy
-
Others
Find
the comprehensive research report here with a single click:
https://www.coherentmarketinsights.com/market-insight/recombinant-vaccine-market-455
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment